CClinicalTrials.gg
RecruitingNCT07048405ICEBATHUpdated Jun 30, 2026

Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia

An interventional study of Cooling and Biopsies in Brown Adipose Tissue, Cold Exposure and 18F-FDG PET/CT, sponsored by University of Edinburgh. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by University of Edinburgh · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This clinical trial explores how repeated short-term cold exposure impacts the molecular and physiological function of brown adipose tissue (BAT), a thermogenic organ associated with improved cardiometabolic health. While intermittent cold exposure has been shown to increase BAT activity and mass, as measured by fluorodeoxyglucose (18F-FDG) uptake on positron emission tomography/computed tomography (PET/CT) scans, the molecular adaptations within BAT and other thermogenic tissues including skeletal muscle and white adipose tissue (WAT) remain poorly understood.

Healthy adults aged 18 to 40 years (6 males and 6 females) will participate in a 10-day cold acclimation protocol (2 hours per day using water-perfused cooling blankets). The primary objective is to determine how cold exposure alters cellular heterogeneity and gene expression in BAT, WAT, and skeletal muscle.

Participants will undergo baseline assessments, including measurements of energy expenditure, core and skin temperature, muscle activity, and blood sampling, each performed in both warm and cold conditions. These assessments will be followed by dynamic total-body PET/CT imaging during cold exposure and tissue biopsies from BAT, subcutaneous WAT, and skeletal muscle. These procedures will be repeated after the cold acclimation protocol to evaluate physiological and molecular changes. Additional outcomes include changes in energy expenditure, cold tolerance, and immune cell responses induced by cold exposure.

Read the detailed description

Twelve healthy adults aged 18-40 years old (6 female, 6 male) will:

  • Attend baseline visits in both warm and cold conditions for blood sampling, measurement of energy expenditure, skin and core temperature, muscle activity. This will be followed by dynamic total-body 18F-FDG PET/CT scan during cold exposure.
  • Undergo biopsies of BAT (supraclavicular), skeletal muscle (vastus lateralis), and subcutaneous WAT (periumbilical) under local anesthesia.
  • Complete 10 consecutive days of cold acclimation (2 hours per day) using water-perfused cooling blankets.
  • Return for follow-up assessments, including repeat blood sampling, energy expenditure, temperature measurements, PET/CT imaging, and tissue biopsies to evaluate post-acclimation changes.
02

Conditions studied

  • Brown Adipose Tissue
  • Cold Exposure
  • 18F-FDG PET/CT

Keywords

  • Brown Adipose Tissue
  • Cold Exposure
  • 18F-FDG PET/CT
03

In context

Lead sponsor

University of Edinburgh is the lead sponsor of 393 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 18-40 years
  • Body mass index 18.5-25 kg/m2
  • Weight change of less than 5% in the past 6 months
  • No acute or chronic medical conditions
  • On no regular medications (other than contraceptives in female participants)
  • No claustrophobia
  • Alcohol intake ≤14 units/ week
  • Screening blood tests within acceptable limits (of no clinical significance)
  • Not currently pregnant, lactating or breastfeeding (female participants only)
  • Ability to provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • Not meeting inclusion criteria
  • Contra-indication to PET/CT scan
  • Allergy to local anaesthetic
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Healthy normal weight subjects

    Other: Cooling · Procedure: Biopsies · Radiation: Injection of 18F-FDG · Other: Indirect calorimetry · Other: Electromyogram · Other: Core and skin temperature monitoring

Interventions

  • OtherCooling

    Participants will undergo cold exposure during the baseline and final visits (2.5 hours each visit), as well as throughout the 10-day cold acclimation period (2 hours per day). This will be achieved using water-perfused blankets set to individualized temperatures, selected to elicit comparable physiological responses across participants.

  • ProcedureBiopsies

    Under local anesthesia, biopsies will be obtained from the following sites: * Brown adipose tissue from the supraclavicular (collarbone) region, guided by computed tomography (CT). * White adipose tissue from the abdominal (periumbilical) area. * Skeletal muscle from the outer thigh, specifically the vastus lateralis. These biopsies will be performed both before and after the 10-day cold acclimation protocol.

    Also known as: brown adipose tissue biopsy, white adipose tissue biopsy, skeletal muscle biopsy

  • RadiationInjection of 18F-FDG

    Intravenous injection of 18F-FDG will be performed after 2 hours of cold exposure. This will be followed by a 30min dynamic total PET/CT scan while cold exposed using water-perfused blankets. These procedures will take place before and after the 10 day-cold acclimation protocol.

  • OtherIndirect calorimetry

    Participants will rest quietly while oxygen consumption and carbon dioxide production are continuously recorded using a indirect calorimeter. These data will be used to calculate energy expenditure and respiratory exchange ratio. This procedure will take place before and after the 10 day-cold acclimation protocol.

  • OtherElectromyogram

    Skin surface electrodes will be placed on major skeletal muscles to measure shivering and muscle activity during both warm and cold conditions. This procedure will take place before and after the 10 day-cold acclimation protocol.

  • OtherCore and skin temperature monitoring

    Participants will ingest an electronic capsule that wirelessly and continuously monitors core body temperature. This procedure will be conducted before and after the 10-day cold acclimation protocol. Additionally, wireless temperature sensors will placed at multiple standardized sites on the body to measure skin temperature. This procedure will be performed before, during, and after the 10-day cold acclimation protocol.

06

What researchers measure

Primary outcomes

  1. Tissue transcriptional changes derived from cold exposure

    We will be analysing and comparing gene expression from nuclei extracted from BAT, WAT and skeletal muscle before and after cold the 10-day cold acclimation protocol.

    Time frame: 1 year

Secondary outcomes

  1. Changes in brown adipose tissue activity/mass before and after cold acclimation protocol

    BAT activity/mass will be measured using the glucose analogue 18-FDG radiotracer combine with PET/CT.

    Time frame: year after

  2. Energy expenditure

    Energy expenditure measured with indirect calorimetry before and after cold acclimation protocol to evaluated any changes in response to intermittent cold exposure.

    Time frame: year after

  3. Skin and core temperature

    Measurement of skin and core temperature before and after the cold acclimation protocol

    Time frame: year after

  4. Immune cell levels

    Analyse the percentage of immune cell populations before and after cold acclimation

    Time frame: year after

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07048405
Lead sponsor
University of Edinburgh
Responsible party
Sponsor
First posted
Jul 2, 2025
Start date
May 1, 2025
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Jun 30, 2026

Study contacts

María Paula Huertas Caycedo
Contact
m.p.huertas-caycedo@sms.ed.ac.uk
01312429196

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion